| Primary information |
|---|
| ID | 1373 |
| Peptide Name | A2.101-108 |
| Sequence | CDVGSDWR |
| Length | 8 |
| Chirality | L |
| N-terminal Modification | None |
| C-terminal Modification | None |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Nature | Protein Derived |
| Source of Origin | α2 domain of HLA-A2 |
| Target | B-Lymphoblastoid cells (B-cell) |
| Mechanism of Action | Inhibit by binding to variable T cell receptor |
| In vitro/In vivo | In vitro |
| Cell Line | JY cells (HKA-A2, B7, DR4,6) |
| Inhibition Concentartion | NA |
| In vivo Model | None |
| Assay | Hummoral Immune Response assay |
| Lethal Dose | NA |
| Combination Therapy | NA |
| Pubmed ID | US 5888512 |
| Year of Publication | 1999 |
| 3-D Structure |  View in Jmol or Download Structure |
